How Can RWE Advance Chronic Disease Research and Inform Decision-Makers?

Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital Dr. Sebastian Schneeweiss recently co-authored a paper with Dr. Elisabetta Patorno on the use of real world evidence (RWE) in chronic disease research, including diabetes. Aetion invited him to share the paper’s findings.

“The comprehensive review paper explores the key considerations for researchers as they generate evidence to inform regulatory, payer, and health technology assessment decision-making, including the importance of transparency in studies, the use of fit-for-purpose data, and ways to avoid bias in study design.” Learn more here.

(Source: Sebastian Schneeweiss, Aetion, 6/3/21)